MedTrace Logo

Mobile Health Self-Management Intervention for Patient With Chronic Obstructive Pulmonary Disease

NCT07469904 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2026-03-27

No results posted yet for this study

Summary

This clinical trial aims to evaluate the effectiveness of a pharmacist-led interactive mobile health intervention (serious game) in adults aged 50 years and older with chronic obstructive pulmonary disease (COPD). The study will test whether the intervention improves health status compared with usual care. Secondary outcomes include inhaler technique, medication adherence, health knowledge, dyspnea, clinical events, healthcare utilization, and costs. Participants in the intervention group will receive pharmacist guidance and use the serious game at home for 2 weeks.

Conditions

  • COPD
  • COPD (Chronic Obstructive Pulmonary Disease)

Interventions

BEHAVIORAL

Pharmacist-Led mHealth Serious Game

A mobile health serious game designed to support COPD self-management through interactive learning activities. The application provides education on COPD management, inhaler technique training, medication reminders, and guidance on recognizing and managing exacerbations.

OTHER

Usual Care

Participants will receive standard COPD care and routine education provided by healthcare professionals according to usual clinical practice.

Sponsors & Collaborators

  • Taipei Medical University

    collaborator OTHER

  • Universitas Katolik Widya Mandala Surabaya

    lead OTHER

Principal Investigators

  • Shawn Hsiang-Yin Chen, Professor · Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-26
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07469904 on ClinicalTrials.gov